Everett Laboratories

Everett Laboratories is a provider of domain valuation services, delivering precise pricing information using an efficient online platform, catering to a diverse clientele including individual investors and corporate entities. Everett Laboratories specializes in domain valuation, allowing clients to submit appraisal requests through its online platform. The company was acquired by Chemo Group in 2010 from Mangrove Equity Partners, with financial terms undisclosed. The firm's headquarters is located in City of Orange, US, and it has completed two deals since its inception.

Everett Labs specializes in providing domain valuation services, focusing on delivering accurate pricing information to clients within a 24-business-hour timeframe. Their core offering includes a user-friendly online platform where potential customers can submit requests for domain appraisals. This service caters to a diverse client base, including individual domain investors, corporate entities, and digital marketers looking to acquire or sell domain names. By leveraging expert insights, Everett Labs aims to solve challenges related to domain valuation, ensuring transparency and reliability in the pricing process.

The company services clients across various geographical markets, emphasizing its reach in North America, while also accommodating international inquiries. Everett Labs generates revenue primarily through its domain valuation services, which operate on a transactional basis. Clients seeking domain price assessments can engage the platform by submitting valuation requests, often resulting in a personalized quote based on specific domain characteristics. The structure of these transactions typically follows a direct-to-consumer model, where individuals or businesses directly interact with the service.

While specific pricing details for individual appraisals are proprietary, the company’s revenue is driven by the volume of completed transactions and the value of the domains assessed. This model supports both one-time valuations and possibly recurring requests from clients engaged in active domain trading or investment strategies. Everett Laboratories plans to develop new features for its online platform, enhancing user experience and efficiency in domain appraisals. The company is also targeting expansion into additional international markets, particularly in Europe and Asia, by 2025.

Recent funding from the acquisition by Chemo Group will be utilized to support these growth initiatives, with a focus on product development and market outreach.